SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-106288
Filing Date
2021-08-16
Accepted
2021-08-16 16:08:01
Documents
15
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125204d1_8k.htm   iXBRL 8-K 30672
2 EXHIBIT 99.1 tm2125204d1_ex99-1.htm EX-99.1 204310
7 GRAPHIC logo.jpg GRAPHIC 4894
  Complete submission text file 0001104659-21-106288.txt   487120

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fbio-20210816.xsd EX-101.SCH 3768
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20210816_def.xml EX-101.DEF 27401
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20210816_lab.xml EX-101.LAB 37128
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20210816_pre.xml EX-101.PRE 26026
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2125204d1_8k_htm.xml XML 5449
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 211178109
SIC: 2834 Pharmaceutical Preparations